AbbVie
AbbVie is a global biopharmaceutical company developing innovative medicines across immunology, oncology and neuroscience, with clinical research and patient support programmes in 170+ countries.
AbbVie is a global biopharmaceutical company that discovers and delivers innovative medicines and solutions for complex health problems. Founded in 2013 and building on a legacy from Abbott Laboratories, it employs approximately 57,000 people and operates in more than 170 countries. Its work spans immunology, oncology, neuroscience and other therapeutic areas, alongside clinical research and personalised patient support programmes.
The company's technical and scientific domains cover biopharmaceutical research and development, clinical research, immunology, oncology and neuroscience, as well as personalised patient support programmes and data privacy and compliance. Products include innovative medicines developed across multiple therapeutic areas to raise the standard of care, and patient-first support programmes that run alongside medicine development and clinical research.
AbbVie describes its mission as discovering and delivering innovative medicines to enhance people's lives, with a patient-first approach from clinical research through to patient support. Stated commitments include full transparency and compliance with policies, and fairness and transparency in the handling of personal data.
